Ritlecitinib in Alopecia Areata: A Multicenter Retrospective Real-World Analysis

Published: 9 June 2025| Version 1 | DOI: 10.17632/3nwy2ftbpx.1
Contributor:
张 文涵

Description

Supplemental Figure 1 detailing the SALT score changes before and after treatment discontinuation in 11 patients. Supplemental Table 1 detailing the demographic characteristics of all patients and Supplemental table 2 detailing SALT50 and SALT75 efficacy in patients of different clinical characteristics.

Files

Categories

Alopecia Areata

Funders

Licence